Geron Corp (NASDAQ:GERN)

2.34
Data as of 11:42am ET
 0.00 / 0.00%
Today’s Change
1.31
Today|||52-Week Range
7.36
-47.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$367.2M

Company Description

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of telomerase. Based on clinical data, they may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, which includes patients with primary MF, post-essential thrombocythemia MF, myelodysplastic syndromes, acute myelogenous leukemia. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Contact Information

Geron Corp.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 473-7700
Investor Relations:
(650) 473-7765

Employees

Shareholders

Individual stakeholders6.23%
Mutual fund holders31.52%
Other institutional19.83%

Top Executives

John A. ScarlettPresident, Chief Executive Officer & Director
Olivia K. BloomChief Financial Officer, Treasurer & Executive VP
Melissa A. Kelly BehrsExecutive Vice President-Business Development
Andrew J. GrethleinExecutive VP-Development & Technical Operations
Anna KrassowskaHead-Investor & Media Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.